Skip to content
Home/Companies/Biotech/Calysens

Calysens

Biotech·France·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Calysens?

Calysens is a French Biotech company, currently owned by OBRATORI, L'Occitane Group Ventures since 2021.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
OBRATORI, L'Occitane Group Ventures
Investor
OBRATORI, L'Occitane Group Ventures
Obratori · 2019 · VC

Key facts

HQFrance
SectorBiotech

More from Obratori

Other portfolio companies in the same fund.

Plasana Medical
Active
France· 2025
Sweetech
Active
France· 2025
ClearDrop/ClearSolar
Active
France· 2024
Humble +
Humble +
Active
ConsumerFrance· 2024
Lazare Studio
Lazare Studio
Active
ConsumerFrance· 2024
Carton Vert
Carton Vert
Active
ClimateTechFrance· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Calysens?

Calysens is currently owned by OBRATORI, L'Occitane Group Ventures, through Obratori, since 2021.

When did OBRATORI, L'Occitane Group Ventures acquire Calysens?

OBRATORI, L'Occitane Group Ventures acquired Calysens in 2021.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue